Phase 3 trials for three different agents show substantial reductions in kidney function decline and other improvements ...

A benign biopsy result can be reassuring — but it only reflects the tissue sampled. Learn why clinical context is essential before closing the case.

Listener feedback on the nonobstructive HCM trials, AI-enhanced visits, timing of non-culprit PCI in STEMI, new tricuspid ...

Patients report waiting a mean of 14 years for an IL-1-mediated autoinflammatory diagnosis. What to recognize, when to test, and how to use IL-1 blockade.

Five modulators, one receptor, very different risk profiles. Andrea De Censi, MD, calls low-dose tamoxifen a new standard for prevention; others want more evidence.

Upadacitinib, a JAK1 inhibitor, is linked to a lower risk for treatment failure and more steroid-free disease stability than ...

Synthesizing medical management strategies with surgical and interventional treatments improves outcomes in patients with ...

Everyday medical equipment is shedding micro- and nanoplastics into patients, bypassing their bodies’ natural filters and ...

Energy drink use in adolescents may be a marker of sleep debt, and clinicians should treat it as a cue to screen for short ...

Adults in late midlife who volunteer show a lower prevalence of high blood pressure than those who do not, regardless of ...

A pooled phase 3 analysis shows that 15-mg and 20-mg doses of estetrol both reduce the frequency and severity of ...

Diabetic peripheral neuropathy is among the most common and debilitating complications of type 2 diabetes, but early ...